TMI-1
TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
398.5
Molecular Formula
C17H22N2O5S2
Notes
Research use only, not for human use.
Receptor
Apoptosis | MMP
CAS Number
287403-39-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1423502-01 0.02 mg (E-Coli)
Recombinant Rat Brain and acute leukemia cytoplasmic protein (Baalc)
Ask
View Details 
MBS1423502-02 0.1 mg (E-Coli)
Recombinant Rat Brain and acute leukemia cytoplasmic protein (Baalc)
Ask
View Details MBS1423502-03 0.02 mg (Yeast)
Recombinant Rat Brain and acute leukemia cytoplasmic protein (Baalc)
Ask
View Details MBS1423502-04 0.1 mg (Yeast)
Recombinant Rat Brain and acute leukemia cytoplasmic protein (Baalc)
Ask
View Details MBS1423502-05 0.02 mg (Baculovirus)
Recombinant Rat Brain and acute leukemia cytoplasmic protein (Baalc)
Ask
View Details 
MBS1423502-06 0.02 mg (Mammalian-Cell)
Recombinant Rat Brain and acute leukemia cytoplasmic protein (Baalc)
Ask
View Details